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Abstract We report here that, upon UV irradiation or growth
stimulation, endogenous c-Jun (40 kDa) in chicken embryo
fibroblasts (CEF) is converted into several forms with apparently
higher molecular weights in SDS-polyacrylamide gel electro-
phoresis (45, 44, 42 kDa). Two of the bands (44 and 45 kDa)
were transient after growth stimulation, but were much more
persistent after UV irradiation. In both cases, the drastic
mobility shifts were accompanied with the activation of
endogenous JNK activity but not of MAPK activity, and the
bands were shown to represent different phosphorylation states of
c-Jun rather than ubiquitinated c-Jun. Biochemical analysis
indicated that phosphorylation at Ser63 and Ser73 was not
sufficient to produce these drastic mobility shifts, which
additionally required phosphorylation at Thr91 and Thr93.
Substitution of both Ser63 and Ser73 with either Ala or Asp
had no significant effect on the transforming activity of c-Jun,
but the mutants failed to show drastic mobility shifts even after
UV irradiation. These results indicate that Ser63 and Ser73 are
essential for the drastic mobility shifts and further suggest that
the highly phosphorylated forms of c-Jun are not directly
involved in cellular transformation.
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A signi¢cant body of evidence indicates that both transient
and constitutive stimulation of (or in) cells results in trans-
duction of signal to transcriptional factor complexes such as
AP-1 (composed of Fos and Jun family proteins). The process
is thought to involve covalent modi¢cation or changes in the
rate of de novo synthesis of constituent proteins, resulting in
modulation of the composition of the complexes [1^3]. One
component of AP-1, c-Jun protein [4], has attracted particular
interest because of its broad and pivotal range of biological
functions in cellular growth, di¡erentiation, transformation
and apoptosis. For example, high-level expression of c-Jun
alone is su⁄cient to induce cellular transformation in chicken
embryo ¢broblasts (CEF) [5^7] or established rodent ¢bro-
blasts [8]. Constitutive expression of such oncogenes as src,
ras and raf in CEF, was shown to cause the elevation of
endogenous AP-1 activity via the elevation of c-Jun and
Fra-2 expression [9]. Since dominant negative mutants of
Fos or Jun family proteins e⁄ciently suppress transformation
induced by these oncogenes, AP-1 activation is essential for
these cellular transformations [9,10].
The N-terminal region of c-Jun is phosphorylated by c-Jun
N-terminal kinase (JNK) [11^13] and the resultant phos-
phorylated c-Jun has been suggested to play important roles
in response to stress or, in some cases, in the maintenance of
cellular transformation [14,15]. c-Jun is also e⁄ciently ubiq-
uitinated both in vitro and in a novel in vivo assay that
utilizes molecularly-tagged ubiquitin [16].
During protein analysis of AP-1 components in CEF, we
have encountered drastic mobility shifts of c-Jun protein upon
either UV irradiation or growth stimulation. We have there-
fore analyzed the molecular events involved in these mobility
shifts and examined the possible biological function of these
modi¢ed forms of c-Jun, especially from the standpoint of
cellular transformation.
2. Materials and methods
2.1. Cell culture and preparation of cell lysates
CEF were kept in Eagle’s minimum essential medium (MEM) sup-
plemented with 5% calf serum (CS), 10% triptose phosphate broth
and 1% DMSO [10]. For starvation, CEF were kept in MEM supple-
mented with 0.2% CS for 24 h as described previously and growth-
stimulated by adding CS to a ¢nal concentration of 15% to the culture
medium [17,18]. For UV irradiation, CEF were kept in MEM without
phenol red, but supplemented with 5% CS, and irradiated using a 254-
nm germicidal lamp (UVP, Inc., Upland, CA, USA) at the dose of 20
J/m2 [18]. CEF were pulse-labeled with [35S]L-methionine (600 WCi per
35-mm dish) for 20 min or with [32P]H3PO4 (500 WCi per 35-mm dish)
for 2 h as described previously [19]. For immunoprecipitation analy-
sis, cell lysates were prepared under denaturing conditions in the
presence of phosphatase inhibitors (5 mM Na3VO4 and 10 mM
NaF) [18,19]. The cell lysate for in-gel kinase assay and for Western
blotting analysis was prepared as follows: cells were washed twice
with PBS, disrupted by adding the sample bu¡er (61.2 mM Tris-
HCl, pH 6.8, 1.96% SDS, 9.8% glycerol and 2.45% L-mercaptoetha-
nol) and boiled for 15 min. Protein amounts were determined by using
a Bio-Rad protein assay kit.
2.2. Construction of plasmids
BglII-BamHI fragments (1.0 kb) encoding the wild-type or mutant
c-Jun (rat) fused to a 6U histidine tag at the N-terminus were isolated
from pCB-wtJ, pCB-SSAA and pCB-SSDD (a kind gift from T. Cur-
ran) [20,21]. They were inserted into the unique BglII site of pDS3 [22]
to generate pDS3-wtJ, pDS3-SSAA and pDS3-SSDD, respectively.
The 1.3-kb HincII fragment encoding JNK1 (a kind gift from R.J.
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Davis) [14] was inserted into the unique SmaI site of a chimeric vec-
tor, pSK118, which was generated by ligating the 1.8-kb ScaI-SmaI
fragment of pBluescript (SK+) and the 1.4-kb ScaI-SmaI fragment of
pUC118. The resultant plasmid was digested with BamHI, and the
fragment encoding JNK1 was inserted into the unique BglII site of
pDS3 to generate pDS3-JNK1.
2.3. Virus vector preparation
For the production of recombinant viruses, pDS3-wtJ, pDS3-
SSAA, pDS3-SSDD, pJH-1 (encoding human c-Jun) [6] and pDS3-
JNK1 were each completely digested with SalI and ligated with the
SalI digest of pREP(A) to form the structure of a replication-compe-
tent provirus (subgroup A). Ligated DNAs (2 Wg) were transfected
into CEF as described previously [22], and replication-competent virus
stocks were collected from the culture 5 or 6 days after transfection.
2.4. Protein analysis
The 35S- or 32P-labeled lysates were immunoprecipitated with anti-
c-Jun (#14) antiserum which is non-crossreactive to other Jun family
proteins, as described previously [19]. For Western blotting, whole cell
extracts (20 Wg) were separated by electrophoresis on SDS-10% poly-
acrylamide gel, immunoblotted with a⁄nity-puri¢ed anti-c-Jun (#10)
antiserum [6] and visualized by use of the ECL Western blotting
detection system (Amersham). In-gel kinase assays for JNK and
MAPK were performed as described previously using the c-Jun N-
terminal region produced by pQE30 (c-JunCD) (40 Wg/ml) or MBP
(myelin basic protein, 0.5 mg/ml) as the substrates [11,18,23].
For dephosphorylation analysis, the immunoprecipitates were solu-
bilized by boiling for 2 min in bu¡er I (50 mM Tris-HCl, pH 8.0,
2 mM PMSF, 0.05 mg/ml antipain, 0.05 mg/ml leupeptin, 0.5% Tra-
sylol, 0.3% SDS and 5 mM DTT), and then diluted with 3 volumes of
bu¡er II (1.3% NP-40, 1.3% deoxycholate-Na and 200 mM NaCl)
before being treated with calf intestinal alkaline phosphatase (CIP)
[24].
For tryptic mapping, 32P-labeled c-Jun protein bands separated on
SDS-10 polyacrylamide gel were excised from the gels, subjected to
trypsin digestion and applied to thin layer cellulose plates for two-
dimensional peptide mapping as described previously [25].
3. Results and discussion
3.1. Transient and prolonged induction of drastic mobility shifts
of c-Jun
For the analysis of AP-1 components synthesized after UV
irradiation, logarithmically growing CEF were pulse-labeled
before and after UV irradiation and disrupted to prepare
cell lysates under denaturing conditions at the time indicated
(Fig. 1, upper panel). Similarly, cell lysates were prepared
from pulse-labeled cultures before and after growth stimula-
tion of serum-starved CEF by adding serum (Fig. 1, lower
panel). While logarithmically growing or growth-arrested
CEF expressed c-Jun as a strong band of 40 kDa, we detected
drastic mobility shifts of c-Jun protein after UV irradiation or
growth stimulation (Fig. 1). Just after UV irradiation, c-Jun
formed a major band of 44 kDa together with three faint
bands with apparent molecular weights of 45 kDa, 42 kDa
and 40 kDa (Fig. 1, upper panel, 20 min). The shifted bands
of endogenous c-Jun remained detectable for at least 320 min.
At around 60 min after irradiation, all of these protein bands
were much denser than at 20 min, indicating that the synthetic
rate of c-Jun increased markedly after UV irradiation.
Growth stimulation was also accompanied with c-Jun mobil-
ity shifts, though these were transient, being detectable only
20 min after the stimulation. When AP-1 components were
puri¢ed from UV-irradiated CEF by means of DNA a⁄nity
chromatography, all these forms of c-Jun (45-, 44-, 42-, 40-
kDa bands) were detected [18], indicating that all of them
retain DNA binding activity (data not shown).
Small mobility shifts of c-Jun have been reported to occur
in CEF [27^29] or other ¢broblasts after UV irradiation,
though not after serum stimulation, but such a drastic mobil-
ity shift of c-Jun has not been reported before in any ¢bro-
blasts. Therefore, we were interested in the molecular mecha-
nisms involved in the production of these unique c-Jun forms
and also in their possible biological function. We ¢rst exam-
ined the possibility of ubiquitination, because the highest mo-
bility shift corresponded to an apparent increase in molecular
weight of 5 kDa, which roughly corresponds to mono-ubiq-
uitination. To prepare large amounts of these unique forms of
c-Jun, CEF were infected with a virus vector carrying His-
tagged c-Jun (wild type) and UV-irradiated. From these cells,
more than 1 Wg of exogenous c-Jun proteins was puri¢ed by
Ni-NTA column chromatography and analyzed by Western
blotting using anti-ubiquitin antiserum [30]. While this serum
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Fig. 1. Patterns of c-Jun biogenesis and endogenous activity of JNK
or MAPK after either UV irradiation (UV) or growth stimulation
(serum). At time 0, logarithmically growing CEF were UV-irradi-
ated (20 J/cm2) or growth-arrested CEF were supplemented with CS
(¢nal 15%). Whole cell lysates for in-gel kinase assay were prepared
at the times indicated. The parallel cultures were pulse-labeled with
[35S]methionine for 20 min and cell lysates were prepared under de-
naturing conditions at the times indicated. Labeled lysates were im-
munoprecipitated with anti-c-Jun (#14) antiserum, resolved on an
SDS-10% polyacrylamide gel and visualized by £uorography
(upper). The non-labeled lysates were separated in SDS-10% poly-
acrylamide gel containing the c-Jun N-terminal region (middle) or
MBP (lower). After in-gel kinase reaction, 32P-labeled proteins were
detected by autoradiography.
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e⁄ciently recognized proteins conjugated with ubiquitin (cor-
responding to 20 ng of ubiquitin), it failed to detect any c-Jun
band at all (data not shown).
Next, to examine the possibility of phosphorylation, the
total immunoprecipitate with anti-c-Jun antiserum was pre-
pared from 35S-labeled CEF at 40 min after UV irradiation
and treated with bacterial alkaline phosphatase (BAP), potato
acid phosphatase (PAP) or calf intestine alkaline phosphatase
(CIP). Treatment with BAP or PAP generated only intermedi-
ate broad bands (43V41 kDa) (data not shown), while all of
the bands (45, 44, 42 and 40 kDa) were converted to a single
band of 40 kDa by CIP treatment (Fig. 2). This conversion by
CIP treatment was totally abolished by a competitive inhibitor
of alkaline phosphatase, PNPP, indicating that it was due to
dephosphorylation, but not proteolysis by a contaminating
protease. These results indicate that the c-Jun mobility shifts
were exclusively caused by phosphorylation. Since JNKs
(JNK1 and JNK2) have been reported to be responsible for
c-Jun phosphorylation in response to stress [11^13], we next
analyzed the kinetics of the activation of endogenous JNKs as
well as ERK2 (the only known MAPK in CEF) [31], which is
closely related to JNKs and has been suggested to be a can-
didate c-Jun kinase. In both UV irradiation and growth stim-
ulation experiments, the density of 44-kDa and 45-kDa bands
correlated well with JNK activity and not with MAPK activ-
ity, as determined by in-gel kinase assay of parallel cultures
(Fig. 1).
3.2. Phosphorylation state of mobility-shifted c-Jun protein
forms
To analyze in detail the relationship between the mobility
shift and the phosphorylation state, each 32P-labeled c-Jun
protein band in PAGE (Fig. 3B, left panel) was excised
from the gel and analyzed by comparison of two-dimensional
tryptic maps (Fig. 3B, right panel). Because the amino acid
sequences of human, mouse, rat and chicken c-Jun proteins
are highly conserved, the tryptic peptides containing the JNK
phosphorylation sites (consensus sequence; Ser/Thr-Pro) were
expected to be assignable on the basis of previous reports on
mouse or human c-Jun [32^34]. In the single 40-kDa c-Jun
band derived from logarithmically growing CEF labeled with
inorganic [32P]phosphate, a clear spot of phosphopeptide ‘x’
was detected, indicating that one of the representative JNK
phosphorylation sites, Ser73, is e⁄ciently phosphorylated even
in growing CEF. As in the case of 35S-labeled proteins, four
32P-labeled protein bands with molecular weights of 40 kDa
(band 1), 42 kDa (band 2), 44 kDa (band 3) and 45 kDa
(band 4) were detected after UV irradiation. Compared with
the c-Jun band of non-irradiated CEF (UV3), the density of
phosphopeptide ‘y’ in band 1 was signi¢cantly enhanced, ap-
proaching that of ‘x’. In band 2, phosphopeptide ‘v’ became
detectable, and its relative density was signi¢cantly increased
in either band 3 or 4, while the relative intensities of spots ‘x’
and ‘y’ as well as three spots ‘a’, ‘b’ and ‘c’, corresponding to
C-terminal peptides, were little changed among bands 1^4.
Phosphoamino acid analysis of bands 1^4 showed that each
band was composed of phosphoserine (P-Ser) and phospho-
threonine (P-Thr) in various ratios (Fig. 3C). Band 1 con-
tained predominantly P-Ser, while similar amounts of P-Ser
and P-Thr were detected in bands 3 and 4, and the P-Ser/P-
Thr ratio in band 2 was intermediate between those of bands
1 and 3. Therefore phosphopeptides in spot ‘v’ were expected
to be mainly composed of P-Thr, consistent with the previous
report that the peptides that migrated to the similar position
to spot ‘v’ were phosphorylated on Thr91 and/or Thr93
[11,12,34]. For the drastic mobility shifts to 44 kDa and 45
kDa, therefore, phosphorylation of both Thr91 and Thr93
seemed to be essential in addition to the phosphorylation of
Ser63 and Ser73.
3.3. Analysis of substitution mutants at Ser63 and Ser73
In an attempt to increase the levels of the mobility-shifted
forms of c-Jun, we constructed a virus vector encoding JNK1
and introduced it into CEF. However, although JNK1 expres-
sion was induced, no elevation of JNK activity was detected
in these non-transformed cells (data not shown), indicating
that qualitative change rather than quantitative change is es-
sential for elevation of JNK activity. Therefore, we next pre-
pared substitution mutants at Ser63 and Ser73 to analyze the
biochemical and biological functions of the phosphorylation
of these two serine residues (Fig. 4A). In one mutant, SSAA,
both of these serine residues were substituted with alanine to
prevent phosphorylation, while in the other mutant, SSDD,
the same residues were replaced with aspartic acid to mimic
phosphoserine. These two mutants as well as wild-type c-Jun,
were fused with a histidine tag at the N-terminus and intro-
duced into CEF using replication-competent retrovirus vec-
tors. To compare the mobility shifts of these mutants with
those of the wild type, total cell extracts were prepared from
logarithmically growing CEF infected with these virus vectors
before or after UV irradiation. Before UV irradiation, c-Jun
wild type and its two mutants migrated as a single band.
While drastic mobility shifts were observed in the wild type
after UV irradiation, such mobility shifts were completely
abolished in SSAA. SSDD in growing CEF had an apparently
slightly higher molecular weight than wild-type c-Jun, but UV
irradiation did not cause the full mobility shifts. From these
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Fig. 2. Dephosphorylation of c-Jun proteins isolated from UV-irra-
diated CEF by calf intestinal alkaline phosphatase (CIP) treatment.
Logarithmically growing CEF were UV-irradiated and 20 min later
they were pulse-labeled with [35S]methionine for 20 min. Whole cell
lysates were prepared under denaturing conditions and immunopre-
cipitated with anti-c-Jun (#14) antiserum. The immunoprecipitates
were solubilized and split into ¢ve aliquots. They were incubated
for 1 h at 37‡C in the absence (lane 1) or presence of 5 U (lanes 2
and 3) or 10 U (lanes 4 and 5) of CIP with (lanes 3 and 5) or with-
out (lanes 2 and 4) phosphatase inhibitor (10 mM p-nitrophenyl
phosphate; PNPP).
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results, phosphorylation of Ser63 and Ser73 is required for the
drastic mobility shifts although it is not su⁄cient for them, as
we concluded in the previous section.
As shown in Fig. 5, CEF fully infected with c-Jun (rat)
virus assumed an elongated shape compared with those in-
fected with the control vector. The virus stocks formed foci
at the titer of more than 6U105 focus forming units/ml and
formed colonies in soft agar at a similar e⁄ciency as that for
c-Jun (human) virus [6], clearly indicating its transforming
activity. CEF infected with SSAA virus showed very similar
cellular morphology to that of CEF expressing c-Jun wild
type (Fig. 5) and retained similar e⁄ciency of colony forma-
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Fig. 3. Phosphorylation patterns of c-Jun proteins detected in UV-irradiated CEF. A: Schematic representation of c-Jun protein. Numbers refer
to amino acid residues. Individual tryptic peptides (‘y’, ‘x’, ‘v’, and ‘a-b-c’) and phosphorylatable residues (bold letters) are indicated. Amino
acid sequences of the tryptic peptides are compared among chicken, mouse, rat, and human c-Jun. BD: basic domain; LZ: leucine zipper mo-
tif. Shaded boxes indicate phosphorylatable tryptic peptides. B: Two cultures of logarithmically growing CEF were pulse-labeled for 120 min
and one (+) was UV-irradiated at 80 min after the start of labeling while the other (3) was untreated. Whole cell lysates were immunoprecipi-
tated with anti-c-Jun (#14) antiserum and the immunoprecipitates were resolved on SDS-10% polyacrylamide gel and detected by autoradiogra-
phy (left panel). Each of the c-Jun protein bands shown here was excised and analyzed by two-dimensional tryptic phosphopeptide mapping.
The 32P-labeled peptides were visualized by Bio-Imaging Analyzer (right panel). C: A part of each c-Jun protein band shown in B, left panel,
was subjected to partial acid hydrolysis and analyzed by two-dimensional electrophoresis as described previously [26]. The phosphoamino acids
were visualized and their relative radioactivity was measured by Bio-Imaging Analyzer. In the lower panel, the percentage of phosphoserine
and phosphothreonine is shown. PS: phosphoserine; PT: phosphothreonine; PY: phosphotyrosine.
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tion in soft agar, in accordance with a previous report using a
mouse c-Jun mutant, c-JunALA [35]. These results indicate that
the unique forms of c-Jun with high mobility are not essential
for the cellular transformation. It was further con¢rmed by
our observation that c-Jun (human) that was exogenously ex-
pressed in CEF by the retrovirus vector did not contain spot
‘v’ after phosphotryptic mapping (data not shown) like endog-
enous c-Jun (UV3, Fig. 3B, left panel). Furthermore, the
transforming phenotype of SSDD virus-infected CEF was
not signi¢cantly enhanced compared with that of c-Jun (wt)
virus-infected CEF as judged from the cellular morphology
and anchorage-independent growth.
In this report, we have shown that the unique forms of c-
Jun with apparent molecular weights of 45 kDa and 44 kDa
detected in CEF represent forms extensively phosphorylated
by activated endogenous JNKs. This unique feature of c-Jun
in CEF may partly re£ect the relatively high level of activity
of JNKs, which phosphorylate c-Jun at Ser73 even in normally
growing CEF. CEF always have higher endogenous JNK ac-
tivity than NIH3T3, or human tumor cell lines so far exam-
ined, whether logarithmically growing cells or UV-stimulated
cells are compared (our unpublished results), and this pro-
vides further support for our ideas. Our mutational analysis,
however, did not provide any evidence that the highly phos-
phorylated forms of c-Jun contribute to cellular transforma-
tion.
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Fig. 5. Cellular morphology of CEF expressing c-Jun wild type or c-Jun substitution mutants. CEF were infected with DS3 (control vector), or
with vector encoding wtJ (c-Jun wt), SSAA, or SSDD and kept under soft agar for four days before the photographs were taken under a
phase-contrast microscope. The bar corresponds to 100 Wm.
Fig. 4. A: Schematic representation of c-Jun wild type (wt) tagged
with His at the N-terminal or its mutants substituted at both serines
63 and 73 with alanine (SSAA) or with aspartic acid (SSDD). B:
His-tagged c-Jun wt and its substitution mutants were introduced
into CEF using retrovirus vectors. CEF infected with the control
vector (DS3) were also prepared. One of each pair of cultures (+)
was UV-irradiated 40 min before the preparation of cell lysates,
while the other (3) was untreated. Whole cell lysates were analyzed
by Western blotting using a⁄nity-puri¢ed anti-c-Jun (#10) antise-
rum. Under these conditions, endogenous c-Jun protein was not de-
tected.
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